ADAPY
Adaptimmune Therapeutics PLC$0.0300 +0.00 (+20.00%)
Oct 23 4:00 PM ET · prev $0.0250
1 year
−53.8%
from $0.0650 · Oct 24
30 days
+30.4%
from $0.0230
52-week range
$0.001000–0.0650
−54% from high · low Apr 29
Avg volume 20D
247.4K
Sep 30 spike 1.35M
Short interest
1.22M
−0.2%
Days to cover
2.1
at average volume
New fund stakes
0
Q4 2025 13F · 0 exits
Price
Daily candles with volume.
No data for this timeframe.
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q4 2025: 1 added (0 new), 1 trimmed or exited.
- Short sellersSTEADY
Short interest −0.2% to 1.22M shares. 2.1 days to cover.
- TrendUPTREND
8% above its 50-day average.
Who's buying
13F· Q4 20250
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| SIMPLEX TRADING, LLC | ADD | $483.00 |
| RHUMBLINE ADVISERS | TRIM | $95.00 |
| UBS Group AG | DOUBLED | $866.8K |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | $527.0K |
| FMR LLC | TRIM | $44.3K |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | DOUBLED | $5.7K |
| BlackRock, Inc. | NEAR_EXIT | $5.0K |
| RHUMBLINE ADVISERS | TRIM | $745.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
EstimatesRevision history: 🔒 Fresh data — subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data — subscribers only | |||
| Next Q | 🔒 Fresh data — subscribers only | |||
| Current FY | 🔒 Fresh data — subscribers only | |||
| Next FY | 🔒 Fresh data — subscribers only | |||
Short side
FINRA· Sep 30, 20261,216,722
shares short
-0.2%
vs prior settlement
2.1
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Dec 31, 2025 Inst.
SIMPLEX TRADING, LLC — ADD
18,610 shares ($483.00)
Dec 31, 2025 Inst.
RHUMBLINE ADVISERS — TRIM
3,661 shares ($95.00)